Entries by Thomas Gabrielczyk

Italy and Germany block central green deal legislation

The European Commission has scraped a key piece of Green Deal legislation following political shifts within the European Parliament. The move came after Italy, governed by a far-right administration of Georgia Meloni, aligned itself with the European People’s Party (EPP) on the matter.

French Afyren starts production of bio-acids – CEO in interview

AFYREN’s first biorefinery, AFYREN NEOXY, has reached continuous production, marking a key step toward large-scale commercialisation of its bio-based acids. The plant will now ramp up output and fulfill long-term contracts across key sectors like nutrition, cosmetics, and life sciences. European Biotech News talked to CEO Nicolas Sordet about the long and winding road to sucess.

GEA to open food biotech pilot-scale facility in USA

GEA has launched its second Food Application and Technology Center (ATC) globally in the US, to target the largest consumer market for cellular agriculture. The facility features advanced bioreactors and precision fermentation systems that enable companies to test and optimise processes for producing alternative proteins and other novel food products.

SpliceBio SL secures US$135m in Series B financing

SpliceBio SL has baged US$135m in a Series B financing co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors The Barcelona-based company will use the proceeds to advance SB-007 in Stargardt disease and expand its pipeline of meds that regulate splicing.